"It has been an honor to lead the Foundation and work with committed individuals and medical professionals in advancing gastric cancer research and establishing the first HIPAA compliant Registry," Wayne Feinstein said when announcing that he would be stepping down from the chairmanship this summer. He will remain an active member of the Board.
At the recent Board meeting, Feinstein was commended for his superior dedication and leadership since assuming the chairmanship in 2013. The Foundation will pay tribute to Feinstein at this year's A CAUSE FOR HOPE event in November (see below).
Feinstein joined with founder JP Gallagher to establish the foundation in 2009. He became involved while his son was in treatment for gastric cancer. Ben Feinstein lost his battle with the disease at age 20.
Board members Alice Leung and Paul Gottsegen will assume their new roles as Foundation Co-Chairs in mid-June. Both have been active in helping the Foundation expand its visibility and sharpen its strategic focus over the past several years. Alice came to the Foundation after a long career in the biomedical field and has a wealth of knowledge regarding cancer drug development experience.
Paul was a close friend of founder JP Gallagher. He has an impressive blend of business acumen and marketing knowledge from his nearly 30 year career in international business and marketing. He is currently Senior VP, Chief Marketing & Strategy Officer for Mindtree, a global information technology solutions company.